Natural history of chronic hepatitis B virus infection: what determines prognosis after cirrhotic decompensation?
Wei
Lai
L
D000998:Antiviral Agents / Q000627:therapeutic use; D001201:Ascites / Q000401:mortality / Q000628:therapy / Q000821:virology*; D006528:Carcinoma, Hepatocellular / Q000821:virology; D018450:Disease Progression; D004932:Esophageal and Gastric Varices / Q000821:virology; D006471:Gastrointestinal Hemorrhage / Q000821:virology; D006501:Hepatic Encephalopathy / Q000821:virology; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000401:mortality / Q000628:therapy; D006530:Hepatorenal Syndrome / Q000821:virology; D006760:Hospitalization; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications / Q000401:mortality / Q000628:therapy / Q000821:virology*; D008113:Liver Neoplasms / Q000821:virology; D016031:Liver Transplantation; D010538:Peritonitis / Q000382:microbiology / Q000821:virology; D011379:Prognosis; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors
D000998:Antiviral Agents